Sotera Health’s Nelson Labs Acquires Gibraltar Laboratories

The acquisition strengthens Nelson Labs’ outsourced testing capabilities for the pharmaceutical and medical device industries.
Aug 29, 2018
By BioPharm International Editors

Sotera Health, a fully integrated protector of global health, has acquired Fairfield, NJ-based Gibraltar Laboratories, expanding the United States-based analytical testing capabilities of Sotera Health’s Nelson Labs business, the company announced in early August 2018.  Gibraltar Laboratories is a provider of microbiology and analytical chemistry testing for pharmaceutical and medical device manufacturers. The terms of the deal were not disclosed.

Gibraltar, owned by the Prince family since 1970, is known for United States Pharmacopeia (USP) compendial microbiology, sterility assurance, and analytical chemistry testing and runs two laboratories in the New Jersey tri-state area.

“Gibraltar Laboratories is a well-respected laboratory known for its strong customer relationships with US-based pharmaceutical manufacturers,” said Michael B. Petras Jr., CEO of Sotera Health, in an Aug. 8, 2018 company press release. “In addition to its testing expertise, Gibraltar’s facilities are located in the Northeast pharmaceutical corridor, home to many of the top pharmaceutical manufacturers in the United States. This acquisition will expand our presence in this important region and further strengthen our testing capabilities for the pharmaceutical industry.  We welcome Gibraltar’s strong management and expert staff as they join our mission of Safeguarding Global Health.”

“Through the commitment of three generations of the Prince family, as well as our experienced staff of microbiology and chemistry professionals, we have earned a reputation as a reliable, responsive, and highly professional partner for our customers, and we know we have found the same in Sotera Health,” said Dr.  Daniel L. Prince, president of Gibraltar Laboratories, in the company press release.  “My goal is for Gibraltar to continue to build on its long-standing reputation of excellence and continue to expand its offerings.  We accomplish this by becoming part of Sotera Health, a global company whose breadth of services and expansive reach provide extraordinary value to the industries we are proud to serve.”

“Gibraltar’s offerings and the strategic location of its facilities will be a great benefit to our mutual customers, who value working with a trusted partner that can consistently deliver quality, service, and expertise,” said Jeff Nelson, president of Nelson Labs, in the press release.  “The Gibraltar team is known for these values and also has an excellent reputation for designing specialized studies that help manufacturers prove the safety, efficacy, and regulatory compliance of their products.  I am also personally excited to be working directly with Dr. Daniel Prince, who I consider a leading thinker in our field.”

Sotera provides mission-critical services to the medical device, pharmaceutical, tissue, and food industries and operates 63 facilities in 13 countries. Sotera comprises Nelson Labs, Nordion, and Sterigenics.  Nelson Labs offers microbiological and analytical testing and expert advisory services for the medical devices, tissue/implantable products, pharmaceutical, and biologics fields.  Nordion provides cobalt-60 used in the gamma sterilization process, and Sterigenics provides comprehensive contract sterilization and ionization solutions for the medical device, pharmaceutical, food safety, and high-performance materials industries.

Source: Nelson Labs

native1_300x100
lorem ipsum